The Bridge Project is a collaboration between the Koch Institute and the Dana-Farber/Harvard Cancer Center (DF/HCC), designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care. Visit the Bridge Project page to learn more.
To encourage the formation of cross-disciplinary teams, we regularly hold informational sessions, workshops, and symposia based on complex translational problems in cancer. Check below for information about upcoming Bridge Project opportunities and events, or click the listings to the left to view videos from previous events.
NEW for 2017
Bridge Project funding is currently being applied to any aspect of translational cancer research — with preference given to work related to issues of high unmet medical need, for which advances in and/or technologies for early detection, more accurate diagnosis, monitoring, treatment, and prevention are required.
As has been true for other cancer types in the past, this year (2017) we have a special funding opportunity related to ileal carcinoids.
Please send an email to email@example.com and provide a project title, the names of the PIs and their affiliations, the type of award you are applying for (Traditional, Footbridge, or Expansion Grant), and a brief description of the project.
*You will not receive an invitation to submit a full proposal; all should submit a proposal before 5 pm on October 23, 2017. The LOI helps us for planning purposes.
Full applications should be submitted electronically to firstname.lastname@example.org.
The review committee meeting, at which finalists present as a team, will take place on Friday, December 15, 2017. All team members must be available that day for an in-person interview. If your team members cannot make this date, or have time restrictions, please let us know when you submit your letter of intent. Do not submit a proposal application if all PIs are not able to be present on this day.